ResearcherUniversity of Nebraska Medical CenterNo recent work listed
Iman M. Ahmad
Matched on ORCID iD 0000-0002-8543-9084; OpenAlex author ID A5059435816. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells. Co-author DOI 10.3390/biomedicines11092580↗
- Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13092264↗
- Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition. First author DOI 10.1016/j.trsl.2018.12.008↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maher Y. Abdalla · 3 shared papers, 2019–2023 · strength 0.51
- Paper Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells. DOI 10.3390/biomedicines11092580↗
- Paper Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironm… DOI 10.3390/cancers13092264↗
- Paper Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibiti… DOI 10.1016/j.trsl.2018.12.008↗
- Kamiya Mehla · 1 shared paper, 2021 · strength 0.15
- Michael Anthony Hollingsworth · 1 shared paper, 2021 · strength 0.15
- Katie L. Bailey · 1 shared paper, 2019 · strength 0.09
- H. Carlo Maurer · 1 shared paper, 2019 · strength 0.09
- Sushil Kumar · 1 shared paper, 2019 · strength 0.09
- Kasturi Banerjee · 1 shared paper, 2019 · strength 0.09
- Christopher M. Thompson · 1 shared paper, 2019 · strength 0.09
- Kenneth P. Olive · 1 shared paper, 2019 · strength 0.09
- Satyanarayana Rachagani · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.